Arcus Biosciences, Inc. (RCUS) Capital expenditures 2016–2025
Arcus Biosciences, Inc. (RCUS) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$2.0MFY2025 · since FY2016: $4.1M → $2.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.0M | -66.7% |
| FY2024 | $6.0M | -75.0% |
| FY2023 | $24.0M | +300.0% |
| FY2022 | $6.0M | -76.9% |
| FY2021 | $26.0M | +766.7% |
| FY2020 | $3.0M | +55.8% |
| FY2019 | $1.9M | -48.6% |
| FY2018 | $3.7M | -32.1% |
| FY2017 | $5.5M | +34.5% |
| FY2016 | $4.1M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice